WHO Programme For International Drug Monitoring
WHO Programme For International Drug Monitoring
International Drug
Monitoring
Mary Couper and Shanthi Pal
Quality Assurance and Safety of Medicines
Medicines Policy and Standards
WHO Programme for International Drug
Monitoring
WHO HQ + WHO
6 Regional Collaborating
offices Centre, Uppsala
National
Centres
AFRO (Brazzaville)
EMRO (Cairo)
EURO (Copenhagen)
WPRO (Manila)
Noncommunicable
HIV/AIDS, TB and
Diseases and
Malaria and neglected Health Systems and Mental Health
Tropical diseases Services
MEDICINES
Family and
Community Health
Health Security and
Environment Information, Evidence
and Research General Management
Training Courses
Collaborative activities
Amodiaquine + artemisinine
Articles in journals
ICDRA
Training course for public health programmes in Sierra Leone, August, 2008
WHO HQ + WHO
6 Regional Collaborating
offices Centre, Uppsala
National
Centres
Staff of about 50
Research
– new ADR findings, new methodology, technology, methods of
communication
Information centre
Training centre
WHO HQ + WHO
6 Regional Collaborating
offices Centre, Uppsala
National
Centres
86 countries
participate in the WHO Programme on International Drug
Monitoring
Include Argentina, Ghana, Kenya, Nepal, Netherlands,
Nigeria, Russia, Sri Lanka, Tunisia, Uganda, USA
31 Associate Members
Include Ethiopia, Sierra Leoneq and Sudan
Countries not yet participating include Namibia and Slovenia
OTHER 11%
NLD 2%
THA 2%
SWE 2%
ESP 2%
AUS 5%
USA 48%
FRA 5%
CAN 5%
DEU 6%
GBR 12%
Medical practice
National Centres
Manufacturers
http://www.who-umc.org
Merci beaucoup !